FHACT® takes the guess work out of cervical cancer screening

WATCH THE VIDEO >

Get answers,
get FHACT®.
Webinar series.

LEARN MORE >

FHACT® is indicated for HPV-positive ASCUS and LSIL patients.

LEARN MORE >

FHACT® is the only FISH Probe to assess four biomarkers associated with cervical cancer.

Learn More

Latest News

30 Oct 14

Cancer Genetics, Inc. to Report Third Quarter 2014 Financial Results on Monday, November 10 (read more...)

- RUTHERFORD, N.J., Oct. 30, 2014 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), an emerging leader in DNA-based cancer diagnostics, (read more...)
21 Oct 14

Cancer Genetics Inc. Granted Patent for Genomic Probe Set Used in Proprietary Test for Cervical and Other HPV-Associated Cancers (read more...)

- > Issuance of patent 8,865,882 covers four probe set used in CGI's proprietary FISH-based HPV-Associated Cancer Test (FHACT®) > FHACT&(read more...)

Events

05 Jun 15

American Society for Colposcopy & Cervical Pathology

29 May 15

American Society of Clinical Oncology Annual Meeting

21 Mar 15

United States & Canadian Academy of Pathology

Clinicians
Patients